These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2936301)

  • 21. Combination therapy: a way to limit emergence of resistance?
    Michéa-Hamzehpour M; Pechère JC; Marchou B; Auckenthaler R
    Am J Med; 1986 Jun; 80(6B):138-42. PubMed ID: 3088999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of apalcillin alone and in combination with four aminoglycoside antibiotics against Pseudomonas aeruginosa.
    Höffler U
    Chemotherapy; 1986; 32(3):255-9. PubMed ID: 3086049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
    Knothe H
    J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.
    Marks MI; Hammerberg S; Greenstone G; Silver B
    Antimicrob Agents Chemother; 1976 Sep; 10(3):399-401. PubMed ID: 825026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.
    Yasmin F; Akhtar N; Hameed A
    Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro study of netilmicin compared with other aminoglycosides.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1976 Sep; 10(3):526-34. PubMed ID: 10829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study of the effect of sisomicin and other aminoglycosides on the causative agents of surgical infection].
    Navashin PS
    Antibiotiki; 1982 Dec; 27(12):26-9. PubMed ID: 6819812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae.
    Briedis DJ; Robson HG
    Antimicrob Agents Chemother; 1976 Oct; 10(4):592-7. PubMed ID: 825032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of ciprofloxacin (BAYo 9867) against Pseudomonas aeruginosa and ampicillin-resistant Enterobacteriaceae.
    Roy C; Foz A; Segura C; Tirado M; Teixell M; Teruel D
    Infection; 1983; 11(6):326-8. PubMed ID: 6421743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aminoglycoside Concentrations Required for Synergy with Carbapenems against Pseudomonas aeruginosa Determined via Mechanistic Studies and Modeling.
    Yadav R; Bulitta JB; Schneider EK; Shin BS; Velkov T; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of netilmicin, gentamicin, and amikacin.
    Kantor RJ; Norden CW
    Antimicrob Agents Chemother; 1977 Jan; 11(1):126-31. PubMed ID: 402104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital.
    Meyer RD; Lewis RP; Halter J; White M
    Lancet; 1976 Mar; 1(7959):580-3. PubMed ID: 55850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C; Kauffman CA
    Infection; 1978; 6(3):111-5. PubMed ID: 98451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Netilmicin: its in vitro activity and synergism with penicillin compounds.
    Thadepalli H; Roy I
    Chemotherapy; 1980; 26(1):12-20. PubMed ID: 7353438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudomonas aeruginosa resistant to aminoglycosides: an assessment of the currently used methods of disk diffusion and dilution susceptibility.
    Ismaeel NA
    Microbios; 1991; 66(268-269):197-204. PubMed ID: 1907714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.
    Daschner FD; Steffens A; Langmaack H
    Chemotherapy; 1979; 25(5):282-5. PubMed ID: 113178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical comparative evaluation of aminoglycosides.
    Abbate GF; Alagia I; Giaquinto E; Giordano B; Leonessa V; Altucci P
    Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of antibiotic combination therapy as evaluated by the Break-point Checkerboard Plate method for multidrug-resistant Pseudomonas aeruginosa in clinical use.
    Nakamura I; Yamaguchi T; Tsukimori A; Sato A; Fukushima S; Mizuno Y; Matsumoto T
    J Infect Chemother; 2014 Apr; 20(4):266-9. PubMed ID: 24486172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
    Yourassowsky E; Schoutens E; Vanderlinden MP
    Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibility of gentamicin-resistant Pseudomonas aeruginosa.
    Yu PK; Washington JA
    Mayo Clin Proc; 1977 Dec; 52(12):802-5. PubMed ID: 413013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.